Microneedle patch developer Zosano secured the cash from strategic partner Eli Lilly concurrently to a $47.5m initial public offering.

The corporate-backed online content management company will float above its range today, after raising nearly $600m in venture capital.

Bellerophon, which was spun out of biopharmaceutical company Ikaria last year, has filed for an initial public offering on Nasdaq.

The Genomic Health-backed genetic testing company intends to raise $86m from an initial public offering on the New York Stock Exchange.

Spark Therapeutics, a spin-out of Children's Hospital of Philadelphia, is developing gene therapy treatments for a rare blinding disorder and haemophilia.

Mobile game developer Linekong previously $115m in three funding rounds from investors including IDG Capital Partners.

The molecular profiling company, backed by Novo, GlaxoSmithKline and Merck, is seeking to float on Nasdaq.

The Kraft-backed neuromuscular treatment developer is seeking $60m, which will be invested in research and marketing.